Efficacy and Safety of Oglemilast in the Prevention of Exercise-Induced Bronchospasm.
Phase of Trial: Phase II
Latest Information Update: 07 Apr 2012
At a glance
- Drugs Oglemilast (Primary)
- Indications Exercise-induced asthma
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 05 Mar 2012 Actual patient number (24) added as reported by ClinicalTrials.gov.
- 05 Mar 2012 Actual end date (Oct 2006) added as reported by ClinicalTrials.gov.
- 19 May 2006 New trial record.